Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Brain Connectivity Changes in Chronic Fatigue Syndrome
February 2026
New imaging evidence shows altered brain networks during cognitive effort in chronic fatigue syndrome and long COVID patients.
Read more
21 Sep 2016
Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress
Germany, September 12, 2016 – Merck, a leading science and technology company, today announced key symposia and more than 30 presentations of clinical…
25 Jul 2016
Green Tea Used to Improve Cognitive Function of Individuals with Down’s Syndrome
INDIVIDUALS with Down’s syndrome have for the first time experienced an improvement in cognitive function as the result of receiving daily doses of green…
25 Jul 2016
Stem Cells Offer Wider Potential After Restoring Motor Functions in Stroke Patients
THE SUCCESS of a small clinical trial using stem cells to restore the motor functions of stroke patients could have wider implications for the treatment…
19 Jul 2016
World Brain Day 2016 Devoted to the Ageing Brain
London, July 2016 – “It is becoming increasingly clear that neurological disorders, such as stroke and dementia but to name a few, are projected to rise…
10 Jun 2016
New Janssen Phase 3 Data in Patients with Moderately to Severely Active Rheumatoid Arthritis Shows Sirukumab Significantly Inhibited Radiographic Progression and Improves Signs and Symptoms of Disease
London, United Kingdom, 8 June, 2016 – Janssen Research & Development, LLC (Janssen) announced today results from a pivotal Phase 3 study evaluating…
9 May 2016
‘Leaky’ Vessels Answer to Unresponsive Cancer
PROMISING research, which has implications for the development of treatments for medulloblastoma, the most common brain tumour in children, has emerged…
9 May 2016
Brain Rewiring After Stroke May be Answer to Therapy
RECOVERY following a stroke can be difficult, but a new study gives an insight into potential recovery markers and new treatment options.
4 May 2016
Otometrics and Maastrict University Drive Greater Understanding of the Paradigm Shift in Vestibular Assessment with New Master Class
Taastrup, Denmark | April 7, 2016 – GN Otometrics, the leading global manufacturer of hearing and balance instrumentation will host a two-day vestibular…
Loading posts...
« Previous
1
…
50
51
52
53
54
55
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View